@yibeichan/claude-skills 1.0.2
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- package/LICENSE +21 -0
- package/README.md +98 -0
- package/cli.js +272 -0
- package/install.py +240 -0
- package/package.json +44 -0
- package/skills/bidsapp-nidm-standards/SKILL.md +202 -0
- package/skills/bidsapp-nidm-standards/references/babs_config.md +20 -0
- package/skills/bidsapp-nidm-standards/references/cli_arguments.md +76 -0
- package/skills/bidsapp-nidm-standards/references/container_patterns.md +53 -0
- package/skills/bidsapp-nidm-standards/references/nidm_integration.md +403 -0
- package/skills/bidsapp-nidm-standards/references/repo_structure.md +121 -0
- package/skills/bidsapp-nidm-standards/references/testing_patterns.md +82 -0
- package/skills/dicom2fmriprep/SKILL.md +377 -0
- package/skills/dicom2fmriprep/evals/evals.json +26 -0
- package/skills/dicom2fmriprep/references/babs-details.md +407 -0
- package/skills/dicom2fmriprep/references/fmriprep-details.md +250 -0
- package/skills/dicom2fmriprep/references/heudiconv-details.md +243 -0
- package/skills/fmri-ssm/SKILL.md +317 -0
- package/skills/fmri-ssm/references/code_templates.md +1570 -0
- package/skills/fmri-ssm/references/downstream_analysis.md +680 -0
- package/skills/fmri-ssm/references/group_inference.md +608 -0
- package/skills/fmri-ssm/references/hrf_modeling.md +447 -0
- package/skills/fmri-ssm/references/model_catalog.md +436 -0
- package/skills/fmri-ssm/references/paradigm_guide.md +406 -0
- package/skills/fmri-ssm/references/preprocessing.md +614 -0
- package/skills/fmri-ssm.zip +0 -0
- package/skills/neuroimaging-qc/SKILL.md +203 -0
- package/skills/neuroimaging-qc/references/eeg_qc.md +400 -0
- package/skills/neuroimaging-qc/references/fmri_qc.md +343 -0
- package/skills/neuroimaging-qc/references/fnirs_qc.md +430 -0
- package/skills/neuroimaging-qc/references/structural_qc.md +454 -0
- package/skills/neuroimaging-qc/scripts/parse_fmriprep_confounds.py +153 -0
- package/skills/neuroimaging-qc/scripts/parse_mriqc.py +114 -0
- package/skills/neuroimaging-qc/scripts/qc_report.py +295 -0
- package/skills/scientific-writer/SKILL.md +202 -0
- package/skills/scientific-writer/references/citation_styles.md +163 -0
- package/skills/scientific-writer/references/field_conventions.md +245 -0
- package/skills/scientific-writer/references/figures_tables.md +225 -0
- package/skills/scientific-writer/references/reporting_guidelines.md +225 -0
- package/skills.json +54 -0
|
@@ -0,0 +1,163 @@
|
|
|
1
|
+
# Citation Styles Reference
|
|
2
|
+
|
|
3
|
+
## Contents
|
|
4
|
+
1. [Style Selection](#style-selection)
|
|
5
|
+
2. [AMA Style](#ama-style)
|
|
6
|
+
3. [Vancouver Style](#vancouver-style)
|
|
7
|
+
4. [APA Style](#apa-style)
|
|
8
|
+
5. [IEEE Style](#ieee-style)
|
|
9
|
+
6. [Journal-Specific Notes](#journal-specific-notes)
|
|
10
|
+
|
|
11
|
+
---
|
|
12
|
+
|
|
13
|
+
## Style Selection
|
|
14
|
+
|
|
15
|
+
| Style | Disciplines | In-Text Format |
|
|
16
|
+
|-------|-------------|----------------|
|
|
17
|
+
| AMA | Medicine, health sciences | Superscript¹ |
|
|
18
|
+
| Vancouver | Biomedical sciences | Brackets [1] |
|
|
19
|
+
| APA | Psychology, social sciences | Author-date (Smith, 2023) |
|
|
20
|
+
| IEEE | Engineering, CS | Brackets [1] |
|
|
21
|
+
| Nature | Multidisciplinary | Superscript¹ |
|
|
22
|
+
|
|
23
|
+
**Rule**: Always check target journal's author guidelines first.
|
|
24
|
+
|
|
25
|
+
---
|
|
26
|
+
|
|
27
|
+
## AMA Style
|
|
28
|
+
|
|
29
|
+
**In-text**: Superscript numbers in order of appearance, outside periods/commas.
|
|
30
|
+
```
|
|
31
|
+
Several studies demonstrated this effect.¹ The results were inconclusive,²
|
|
32
|
+
although Smith et al³ reported otherwise. Multiple studies¹,³,⁵⁻⁷ confirmed this.
|
|
33
|
+
```
|
|
34
|
+
|
|
35
|
+
**Journal article**:
|
|
36
|
+
```
|
|
37
|
+
1. Smith JD, Johnson AB, Williams CD. Title of article. JAMA Psychiatry.
|
|
38
|
+
2023;80(5):456-464. doi:10.1001/jamapsychiatry.2023.0123
|
|
39
|
+
```
|
|
40
|
+
|
|
41
|
+
**Book**:
|
|
42
|
+
```
|
|
43
|
+
2. Author AA. Book Title. 2nd ed. Publisher; 2023.
|
|
44
|
+
```
|
|
45
|
+
|
|
46
|
+
**>6 authors**: List first 3, then "et al."
|
|
47
|
+
|
|
48
|
+
---
|
|
49
|
+
|
|
50
|
+
## Vancouver Style
|
|
51
|
+
|
|
52
|
+
**In-text**: Numbers in square brackets before periods.
|
|
53
|
+
```
|
|
54
|
+
Several studies showed this effect [1]. The results were inconclusive [2],
|
|
55
|
+
although Smith et al [3] reported otherwise. Multiple studies [1,3,5-7] confirmed this.
|
|
56
|
+
```
|
|
57
|
+
|
|
58
|
+
**Journal article**:
|
|
59
|
+
```
|
|
60
|
+
1. Smith JD, Johnson AB, Williams CD. Title of article. JAMA Psychiatry.
|
|
61
|
+
2023;80(5):456-464.
|
|
62
|
+
```
|
|
63
|
+
|
|
64
|
+
**>6 authors**: List first 6, then "et al."
|
|
65
|
+
|
|
66
|
+
**Journal abbreviations**: Use PubMed/Index Medicus abbreviations.
|
|
67
|
+
|
|
68
|
+
---
|
|
69
|
+
|
|
70
|
+
## APA Style (7th Edition)
|
|
71
|
+
|
|
72
|
+
**In-text**: Author-date format.
|
|
73
|
+
```
|
|
74
|
+
One study found significant effects (Smith, 2023).
|
|
75
|
+
Smith (2023) found significant effects.
|
|
76
|
+
(Smith & Jones, 2023) — two authors
|
|
77
|
+
(Smith et al., 2023) — three+ authors
|
|
78
|
+
"Direct quote" (Smith, 2023, p. 45).
|
|
79
|
+
```
|
|
80
|
+
|
|
81
|
+
**Journal article**:
|
|
82
|
+
```
|
|
83
|
+
Smith, J. D., Johnson, A. B., & Williams, C. D. (2023). Title of article.
|
|
84
|
+
JAMA Psychiatry, 80(5), 456-464. https://doi.org/10.1001/jamapsychiatry.2023.0123
|
|
85
|
+
```
|
|
86
|
+
|
|
87
|
+
**Capitalization**: Sentence case for titles, title case for journals.
|
|
88
|
+
|
|
89
|
+
---
|
|
90
|
+
|
|
91
|
+
## IEEE Style
|
|
92
|
+
|
|
93
|
+
**In-text**: Numbers in square brackets.
|
|
94
|
+
```
|
|
95
|
+
Several studies [1] demonstrated this. The findings [1]-[3] suggest...
|
|
96
|
+
Smith [4] showed that multiple factors [4], [5] contributed.
|
|
97
|
+
```
|
|
98
|
+
|
|
99
|
+
**Journal article**:
|
|
100
|
+
```
|
|
101
|
+
[1] J. D. Smith and A. B. Johnson, "Title of article," JAMA Psychiatry,
|
|
102
|
+
vol. 80, no. 5, pp. 456-464, 2023, doi: 10.1001/jamapsychiatry.2023.0123.
|
|
103
|
+
```
|
|
104
|
+
|
|
105
|
+
**Conference paper**:
|
|
106
|
+
```
|
|
107
|
+
[2] J. D. Smith, "Title of paper," in Proc. Conf. Name, City, Country, 2023, pp. 1-8.
|
|
108
|
+
```
|
|
109
|
+
|
|
110
|
+
---
|
|
111
|
+
|
|
112
|
+
## Journal-Specific Notes
|
|
113
|
+
|
|
114
|
+
| Journal | Style | Key Features |
|
|
115
|
+
|---------|-------|--------------|
|
|
116
|
+
| JAMA Network | AMA | Superscript, abbreviated journals, no issue |
|
|
117
|
+
| NEJM | Vancouver | Brackets, 3 authors then et al |
|
|
118
|
+
| Lancet | Vancouver | PubMed abbreviations |
|
|
119
|
+
| Nature | Nature style | Superscript, no article titles |
|
|
120
|
+
| Cell Press | Cell style | Author-year |
|
|
121
|
+
| PLOS | Vancouver | Brackets, some use full journal names |
|
|
122
|
+
| IEEE journals | IEEE | Brackets, specific conference format |
|
|
123
|
+
|
|
124
|
+
### High-Impact Journals
|
|
125
|
+
- **Nature/Science**: Numbered, abbreviated, space-saving
|
|
126
|
+
- **NEJM/Lancet/JAMA**: Vancouver/AMA numbered
|
|
127
|
+
- **Cell family**: Author-date
|
|
128
|
+
|
|
129
|
+
### ML Conferences
|
|
130
|
+
- **NeurIPS/ICML/ICLR**: Check template; arXiv preprints accepted
|
|
131
|
+
- **CVPR/ICCV**: IEEE-like numbered
|
|
132
|
+
- **ACL/EMNLP**: Author-year (ACL style)
|
|
133
|
+
|
|
134
|
+
---
|
|
135
|
+
|
|
136
|
+
## Special Cases
|
|
137
|
+
|
|
138
|
+
**Preprints**:
|
|
139
|
+
```
|
|
140
|
+
APA: Author, A. A. (Year). Title [Preprint]. bioRxiv. https://doi.org/xx.xxxx
|
|
141
|
+
```
|
|
142
|
+
|
|
143
|
+
**Software**:
|
|
144
|
+
```
|
|
145
|
+
APA: Author, A. A. (Year). Package name (Version X.X) [Software]. URL
|
|
146
|
+
```
|
|
147
|
+
|
|
148
|
+
**Datasets**:
|
|
149
|
+
```
|
|
150
|
+
APA: Author, A. A. (Year). Dataset title (Version X) [Data set]. Repository.
|
|
151
|
+
https://doi.org/xx.xxxx
|
|
152
|
+
```
|
|
153
|
+
|
|
154
|
+
---
|
|
155
|
+
|
|
156
|
+
## Citation Quality Checklist
|
|
157
|
+
|
|
158
|
+
- [ ] ≥50% from last 5-10 years (2-3 years for ML conferences)
|
|
159
|
+
- [ ] <20% self-citations
|
|
160
|
+
- [ ] Primary sources (not citation chains)
|
|
161
|
+
- [ ] All in-text citations in reference list
|
|
162
|
+
- [ ] DOIs included where available
|
|
163
|
+
- [ ] Style matches target venue exactly
|
|
@@ -0,0 +1,245 @@
|
|
|
1
|
+
# Field-Specific Conventions Reference
|
|
2
|
+
|
|
3
|
+
## Contents
|
|
4
|
+
1. [Biomedical/Clinical](#biomedicalclinical)
|
|
5
|
+
2. [Molecular Biology](#molecular-biology)
|
|
6
|
+
3. [Chemistry](#chemistry)
|
|
7
|
+
4. [Neuroscience](#neuroscience)
|
|
8
|
+
5. [Ecology](#ecology)
|
|
9
|
+
6. [Physics/Engineering](#physicsengineering)
|
|
10
|
+
7. [Social/Behavioral Sciences](#socialbehavioral-sciences)
|
|
11
|
+
8. [Machine Learning/CS](#machine-learningcs)
|
|
12
|
+
|
|
13
|
+
---
|
|
14
|
+
|
|
15
|
+
## Biomedical/Clinical
|
|
16
|
+
|
|
17
|
+
### Terminology
|
|
18
|
+
- Use precise anatomical/clinical terms ("myocardial infarction" not "heart attack")
|
|
19
|
+
- Follow ICD, DSM, SNOMED-CT nomenclature
|
|
20
|
+
- Generic drug names first: "metformin (Glucophage)"
|
|
21
|
+
- "Patients" for clinical studies, "participants" for community research
|
|
22
|
+
|
|
23
|
+
### Genetic Variants
|
|
24
|
+
Follow HGVS nomenclature:
|
|
25
|
+
- DNA: c.76A>T (coding), g.12345A>T (genomic)
|
|
26
|
+
- Protein: p.Arg25Cys or p.R25C
|
|
27
|
+
- Reference sequence required: NM_000123.4:c.76A>T
|
|
28
|
+
|
|
29
|
+
### Units
|
|
30
|
+
- SI units for most international journals
|
|
31
|
+
- Report lab values with reference ranges
|
|
32
|
+
- Blood pressure: mmHg
|
|
33
|
+
- Temperature: °C
|
|
34
|
+
|
|
35
|
+
### Statistics
|
|
36
|
+
- Report absolute numbers with percentages: "32 (64%)"
|
|
37
|
+
- Include 95% CI for main outcomes
|
|
38
|
+
- NNT/NNH for clinical significance
|
|
39
|
+
|
|
40
|
+
---
|
|
41
|
+
|
|
42
|
+
## Molecular Biology
|
|
43
|
+
|
|
44
|
+
### Gene/Protein Nomenclature
|
|
45
|
+
| Species | Gene | Protein |
|
|
46
|
+
|---------|------|---------|
|
|
47
|
+
| Human | *BRCA1* (italic, uppercase) | BRCA1 (regular, uppercase) |
|
|
48
|
+
| Mouse | *Brca1* (italic, sentence case) | Brca1 (regular, sentence case) |
|
|
49
|
+
| General | *gene* (italic) | Protein (regular) |
|
|
50
|
+
|
|
51
|
+
### Species Names
|
|
52
|
+
- Full at first mention: *Escherichia coli*
|
|
53
|
+
- Abbreviated after: *E. coli*
|
|
54
|
+
- Italicize genus and species
|
|
55
|
+
|
|
56
|
+
### Techniques
|
|
57
|
+
- "quantitative PCR" or "qPCR" (not "real-time PCR")
|
|
58
|
+
- "Western blot" (capitalized)
|
|
59
|
+
- "CRISPR-Cas9" (specific system)
|
|
60
|
+
|
|
61
|
+
### Sequence Data
|
|
62
|
+
- Accession numbers required for deposited sequences
|
|
63
|
+
- Report GenBank/EMBL/DDBJ numbers
|
|
64
|
+
|
|
65
|
+
---
|
|
66
|
+
|
|
67
|
+
## Chemistry
|
|
68
|
+
|
|
69
|
+
### Nomenclature
|
|
70
|
+
- IUPAC names for novel compounds
|
|
71
|
+
- Common names acceptable for well-known substances
|
|
72
|
+
- CAS numbers for unambiguous identification
|
|
73
|
+
|
|
74
|
+
### Structure Notation
|
|
75
|
+
- SMILES for machine-readable
|
|
76
|
+
- InChI for databases
|
|
77
|
+
- Chemical drawings following IUPAC conventions
|
|
78
|
+
|
|
79
|
+
### Concentrations
|
|
80
|
+
| Unit | Use Case |
|
|
81
|
+
|------|----------|
|
|
82
|
+
| M, mM, μM, nM | Solution concentration |
|
|
83
|
+
| % w/v | Weight per volume |
|
|
84
|
+
| % v/v | Volume per volume |
|
|
85
|
+
| ppm, ppb | Trace amounts |
|
|
86
|
+
|
|
87
|
+
### Reactions
|
|
88
|
+
- Use standard arrow notation (→, ⇌)
|
|
89
|
+
- Report yields as percentage
|
|
90
|
+
- Specify conditions (temperature, solvent, catalyst)
|
|
91
|
+
|
|
92
|
+
---
|
|
93
|
+
|
|
94
|
+
## Neuroscience
|
|
95
|
+
|
|
96
|
+
### Brain Regions
|
|
97
|
+
- Use standardized nomenclature (Allen Brain Atlas, Paxinos)
|
|
98
|
+
- Specify coordinates: "AP: -3.2, ML: ±2.0, DV: -4.5 from bregma"
|
|
99
|
+
- Abbreviations after first use: "prefrontal cortex (PFC)"
|
|
100
|
+
|
|
101
|
+
### Neural Activity
|
|
102
|
+
| Term | Measurement |
|
|
103
|
+
|------|-------------|
|
|
104
|
+
| "neural activity" | General |
|
|
105
|
+
| "neuronal firing" | Single-unit recording |
|
|
106
|
+
| "brain activation" | fMRI BOLD signal |
|
|
107
|
+
| "oscillations" | LFP/EEG rhythms |
|
|
108
|
+
|
|
109
|
+
### Techniques
|
|
110
|
+
- Specify fully: "whole-cell patch clamp recording"
|
|
111
|
+
- Include sampling rates for electrophysiology
|
|
112
|
+
- Report signal processing parameters
|
|
113
|
+
|
|
114
|
+
### Behavioral Measures
|
|
115
|
+
- Use validated test names exactly
|
|
116
|
+
- Cite original validation papers
|
|
117
|
+
- Report inter-rater reliability if applicable
|
|
118
|
+
|
|
119
|
+
---
|
|
120
|
+
|
|
121
|
+
## Ecology
|
|
122
|
+
|
|
123
|
+
### Taxonomic Names
|
|
124
|
+
- Binomial: *Homo sapiens*
|
|
125
|
+
- Authority at first mention if relevant: *Quercus robur* L.
|
|
126
|
+
- Common names lowercase unless proper nouns
|
|
127
|
+
|
|
128
|
+
### Ecological Metrics
|
|
129
|
+
- "species richness" (count)
|
|
130
|
+
- "Shannon diversity index" (H')
|
|
131
|
+
- "Simpson's diversity index" (D)
|
|
132
|
+
- Report with units and methods
|
|
133
|
+
|
|
134
|
+
### Sampling Methods
|
|
135
|
+
- Standardized terms: "transect," "quadrat," "mark-recapture"
|
|
136
|
+
- Report effort: "100 trap-nights"
|
|
137
|
+
- Include GPS coordinates when appropriate
|
|
138
|
+
|
|
139
|
+
### Habitat Classification
|
|
140
|
+
- Use standardized systems (IUCN, CORINE)
|
|
141
|
+
- Define custom classifications clearly
|
|
142
|
+
|
|
143
|
+
---
|
|
144
|
+
|
|
145
|
+
## Physics/Engineering
|
|
146
|
+
|
|
147
|
+
### Units
|
|
148
|
+
- SI units unless field conventions differ
|
|
149
|
+
- Specify: "5.2 ± 0.3 nm" (value ± uncertainty)
|
|
150
|
+
- Use scientific notation consistently: 3.2 × 10⁸ m/s
|
|
151
|
+
|
|
152
|
+
### Mathematical Notation
|
|
153
|
+
- Scalars: italic (*m*, *v*)
|
|
154
|
+
- Vectors: bold (**v**) or arrow (v⃗)
|
|
155
|
+
- Matrices: bold uppercase (**A**)
|
|
156
|
+
- ℏ for reduced Planck constant
|
|
157
|
+
|
|
158
|
+
### Physical Quantities
|
|
159
|
+
- Define symbols at first use
|
|
160
|
+
- Use established notation for field
|
|
161
|
+
- Consistent notation throughout
|
|
162
|
+
|
|
163
|
+
### Equipment
|
|
164
|
+
- Model numbers and manufacturers
|
|
165
|
+
- Calibration information
|
|
166
|
+
- Operating parameters
|
|
167
|
+
|
|
168
|
+
---
|
|
169
|
+
|
|
170
|
+
## Social/Behavioral Sciences
|
|
171
|
+
|
|
172
|
+
### Language Guidelines
|
|
173
|
+
- Person-first: "people with schizophrenia" not "schizophrenics"
|
|
174
|
+
- Avoid stigmatizing language
|
|
175
|
+
- Follow APA bias-free language guidelines
|
|
176
|
+
- "Participants" not "subjects" for humans
|
|
177
|
+
|
|
178
|
+
### Constructs
|
|
179
|
+
- Use established psychological construct names
|
|
180
|
+
- Cite validated assessment tools
|
|
181
|
+
- Report Cronbach's α for scales
|
|
182
|
+
|
|
183
|
+
### Demographics
|
|
184
|
+
- Report: age (M, SD, range), gender/sex, race/ethnicity, SES
|
|
185
|
+
- Use participant-preferred terminology
|
|
186
|
+
- Follow journal guidelines for demographic reporting
|
|
187
|
+
|
|
188
|
+
### Theoretical Frameworks
|
|
189
|
+
- Name theories explicitly
|
|
190
|
+
- Cite seminal sources
|
|
191
|
+
- Define key constructs operationally
|
|
192
|
+
|
|
193
|
+
---
|
|
194
|
+
|
|
195
|
+
## Machine Learning/CS
|
|
196
|
+
|
|
197
|
+
### Model Description
|
|
198
|
+
- Architecture: "3-layer MLP with 256, 128, 64 units"
|
|
199
|
+
- Activation functions: "ReLU," "softmax"
|
|
200
|
+
- Regularization: "dropout (p=0.5)," "L2 (λ=0.01)"
|
|
201
|
+
|
|
202
|
+
### Training Details
|
|
203
|
+
- Optimizer: "Adam (lr=0.001, β₁=0.9, β₂=0.999)"
|
|
204
|
+
- Batch size, epochs
|
|
205
|
+
- Hardware: "NVIDIA A100, 40GB"
|
|
206
|
+
- Training time
|
|
207
|
+
|
|
208
|
+
### Evaluation
|
|
209
|
+
- Standard metrics with definitions
|
|
210
|
+
- Report mean ± std over multiple runs
|
|
211
|
+
- Include confidence intervals
|
|
212
|
+
- Specify test set (held-out, cross-validation)
|
|
213
|
+
|
|
214
|
+
### Reproducibility
|
|
215
|
+
- Random seeds
|
|
216
|
+
- Dataset splits
|
|
217
|
+
- Code availability
|
|
218
|
+
- Environment specifications (PyTorch version, CUDA)
|
|
219
|
+
|
|
220
|
+
### Terminology
|
|
221
|
+
| Term | Use |
|
|
222
|
+
|------|-----|
|
|
223
|
+
| "model" | The learned function |
|
|
224
|
+
| "architecture" | Network structure |
|
|
225
|
+
| "hyperparameters" | User-set values |
|
|
226
|
+
| "parameters" | Learned weights |
|
|
227
|
+
|
|
228
|
+
---
|
|
229
|
+
|
|
230
|
+
## General Principles
|
|
231
|
+
|
|
232
|
+
### Consistency
|
|
233
|
+
- Same term for same concept throughout
|
|
234
|
+
- One abbreviation system
|
|
235
|
+
- Consistent notation
|
|
236
|
+
|
|
237
|
+
### Audience Matching
|
|
238
|
+
- Specialist journal: technical terms freely
|
|
239
|
+
- Broad journal: define more terms
|
|
240
|
+
- Interdisciplinary: balance precision and accessibility
|
|
241
|
+
|
|
242
|
+
### Verification
|
|
243
|
+
- Check recent papers in target journal
|
|
244
|
+
- Consult field-specific style guides
|
|
245
|
+
- Use domain databases (MeSH, Gene Ontology)
|
|
@@ -0,0 +1,225 @@
|
|
|
1
|
+
# Figures and Tables Reference
|
|
2
|
+
|
|
3
|
+
## Contents
|
|
4
|
+
1. [When to Use Which](#when-to-use-which)
|
|
5
|
+
2. [Figure Design](#figure-design)
|
|
6
|
+
3. [Table Design](#table-design)
|
|
7
|
+
4. [Captions and Legends](#captions-and-legends)
|
|
8
|
+
5. [Common Figure Types](#common-figure-types)
|
|
9
|
+
6. [Statistical Presentation](#statistical-presentation)
|
|
10
|
+
|
|
11
|
+
---
|
|
12
|
+
|
|
13
|
+
## When to Use Which
|
|
14
|
+
|
|
15
|
+
| Use Tables When | Use Figures When |
|
|
16
|
+
|-----------------|------------------|
|
|
17
|
+
| Exact values matter | Trends/patterns matter |
|
|
18
|
+
| Many variables to compare | Relationships to visualize |
|
|
19
|
+
| Precise numbers needed | Quick comprehension desired |
|
|
20
|
+
| Text would be repetitive | Data distribution shown |
|
|
21
|
+
|
|
22
|
+
**General rule**: ~1 table or figure per 1,000 words of text.
|
|
23
|
+
|
|
24
|
+
**Never duplicate**: Information should appear in text, table, OR figure—not multiple.
|
|
25
|
+
|
|
26
|
+
---
|
|
27
|
+
|
|
28
|
+
## Figure Design
|
|
29
|
+
|
|
30
|
+
### Principles
|
|
31
|
+
1. **Self-explanatory**: Reader understands without text
|
|
32
|
+
2. **Clean**: Remove chartjunk, unnecessary gridlines, 3D effects
|
|
33
|
+
3. **Accessible**: Colorblind-friendly, sufficient contrast
|
|
34
|
+
4. **Publication-ready**: 300+ DPI, appropriate file format
|
|
35
|
+
|
|
36
|
+
### Essential Elements
|
|
37
|
+
- Clear title in caption (not on figure)
|
|
38
|
+
- Labeled axes with units
|
|
39
|
+
- Legend if multiple groups/conditions
|
|
40
|
+
- Error bars with definition (SD, SEM, 95% CI)
|
|
41
|
+
- Sample sizes (n)
|
|
42
|
+
- Statistical annotations (* p<0.05, ** p<0.01, *** p<0.001)
|
|
43
|
+
- Scale bars for images
|
|
44
|
+
|
|
45
|
+
### Color Guidelines
|
|
46
|
+
- Use colorblind-friendly palettes (viridis, ColorBrewer)
|
|
47
|
+
- Distinguish by pattern/shape in addition to color
|
|
48
|
+
- Ensure grayscale readability
|
|
49
|
+
- Consistent colors across all figures
|
|
50
|
+
|
|
51
|
+
### Technical Specifications
|
|
52
|
+
|
|
53
|
+
| Format | Use Case | Resolution |
|
|
54
|
+
|--------|----------|------------|
|
|
55
|
+
| TIFF | Print publication | 300-600 DPI |
|
|
56
|
+
| EPS/PDF | Vector graphics | Scalable |
|
|
57
|
+
| PNG | Web/screen | 150+ DPI |
|
|
58
|
+
| JPEG | Photos only | 300 DPI |
|
|
59
|
+
|
|
60
|
+
**Typical dimensions**: Single column (8.5 cm), double column (17.5 cm)
|
|
61
|
+
|
|
62
|
+
---
|
|
63
|
+
|
|
64
|
+
## Table Design
|
|
65
|
+
|
|
66
|
+
### Principles
|
|
67
|
+
1. **Organized**: Logical row/column arrangement
|
|
68
|
+
2. **Sparse**: Minimal lines (top, bottom, header only)
|
|
69
|
+
3. **Aligned**: Decimal alignment for numbers
|
|
70
|
+
4. **Complete**: All abbreviations defined in footnotes
|
|
71
|
+
|
|
72
|
+
### Essential Elements
|
|
73
|
+
- Descriptive title above table
|
|
74
|
+
- Clear column headers with units
|
|
75
|
+
- Consistent decimal places
|
|
76
|
+
- Sample sizes per group
|
|
77
|
+
- Statistical test results
|
|
78
|
+
- Footnotes for abbreviations and symbols
|
|
79
|
+
|
|
80
|
+
### Structure
|
|
81
|
+
```
|
|
82
|
+
Table 1. Baseline characteristics of study participants
|
|
83
|
+
|
|
84
|
+
Characteristic Intervention (n=50) Control (n=50) p-value
|
|
85
|
+
─────────────────────────────────────────────────────────────────────
|
|
86
|
+
Age, years 45.2 ± 12.3 44.8 ± 11.9 0.87
|
|
87
|
+
Female, n (%) 28 (56) 25 (50) 0.55
|
|
88
|
+
BMI, kg/m² 27.4 ± 4.2 28.1 ± 3.9 0.38
|
|
89
|
+
─────────────────────────────────────────────────────────────────────
|
|
90
|
+
Values are mean ± SD unless otherwise indicated.
|
|
91
|
+
BMI, body mass index.
|
|
92
|
+
```
|
|
93
|
+
|
|
94
|
+
### Common Table Types
|
|
95
|
+
1. **Baseline/demographics**: Participant characteristics by group
|
|
96
|
+
2. **Results summary**: Primary/secondary outcomes
|
|
97
|
+
3. **Comparison**: Multiple studies or methods
|
|
98
|
+
4. **Model results**: Regression coefficients, odds ratios
|
|
99
|
+
|
|
100
|
+
---
|
|
101
|
+
|
|
102
|
+
## Captions and Legends
|
|
103
|
+
|
|
104
|
+
### Figure Captions
|
|
105
|
+
|
|
106
|
+
**Format**: Figure [number]. [Title]. [Methods/details]. [Abbreviations].
|
|
107
|
+
|
|
108
|
+
**Example**:
|
|
109
|
+
```
|
|
110
|
+
Figure 2. Effect of treatment on cognitive scores over time. Mean Mini-Mental
|
|
111
|
+
State Examination (MMSE) scores at baseline, 3 months, and 6 months for
|
|
112
|
+
intervention (n=50) and control (n=50) groups. Error bars represent 95%
|
|
113
|
+
confidence intervals. *p<0.05, **p<0.01 vs. control at same timepoint.
|
|
114
|
+
```
|
|
115
|
+
|
|
116
|
+
### Table Titles
|
|
117
|
+
|
|
118
|
+
**Format**: Table [number]. [Descriptive title]
|
|
119
|
+
|
|
120
|
+
**Example**:
|
|
121
|
+
```
|
|
122
|
+
Table 3. Predictors of treatment response in multivariable logistic regression
|
|
123
|
+
```
|
|
124
|
+
|
|
125
|
+
### Caption Checklist
|
|
126
|
+
- [ ] Describes what is shown
|
|
127
|
+
- [ ] Includes sample sizes
|
|
128
|
+
- [ ] Defines error bars/statistical measures
|
|
129
|
+
- [ ] Explains symbols and abbreviations
|
|
130
|
+
- [ ] States statistical tests used
|
|
131
|
+
- [ ] Readable without main text
|
|
132
|
+
|
|
133
|
+
---
|
|
134
|
+
|
|
135
|
+
## Common Figure Types
|
|
136
|
+
|
|
137
|
+
### Bar Graphs
|
|
138
|
+
- Use for comparing discrete categories
|
|
139
|
+
- Include individual data points when n<30
|
|
140
|
+
- Error bars: typically SEM or 95% CI
|
|
141
|
+
- Baseline at zero (don't truncate y-axis)
|
|
142
|
+
|
|
143
|
+
### Line Graphs
|
|
144
|
+
- Use for continuous data over time
|
|
145
|
+
- Connect only related data points
|
|
146
|
+
- Include error bars at each timepoint
|
|
147
|
+
- Distinguish groups by line style AND symbol
|
|
148
|
+
|
|
149
|
+
### Scatter Plots
|
|
150
|
+
- Use for correlations/relationships
|
|
151
|
+
- Include regression line with equation and R²
|
|
152
|
+
- Show confidence bands if appropriate
|
|
153
|
+
- Consider density plots for large n
|
|
154
|
+
|
|
155
|
+
### Box Plots
|
|
156
|
+
- Use for distributions and comparisons
|
|
157
|
+
- Show: median, IQR, whiskers, outliers
|
|
158
|
+
- Define whisker convention (1.5×IQR, range, etc.)
|
|
159
|
+
- Overlay individual points when feasible
|
|
160
|
+
|
|
161
|
+
### Heatmaps
|
|
162
|
+
- Use for matrices, gene expression, correlations
|
|
163
|
+
- Include color scale with units
|
|
164
|
+
- Cluster rows/columns if meaningful
|
|
165
|
+
- Ensure color scale is intuitive
|
|
166
|
+
|
|
167
|
+
### Forest Plots
|
|
168
|
+
- Use for meta-analyses, subgroup analyses
|
|
169
|
+
- Show: effect estimate, CI, weight
|
|
170
|
+
- Include overall effect with diamond
|
|
171
|
+
- Order by effect size or predefined grouping
|
|
172
|
+
|
|
173
|
+
---
|
|
174
|
+
|
|
175
|
+
## Statistical Presentation
|
|
176
|
+
|
|
177
|
+
### Descriptive Statistics
|
|
178
|
+
| Data Type | Report |
|
|
179
|
+
|-----------|--------|
|
|
180
|
+
| Normal continuous | Mean ± SD |
|
|
181
|
+
| Non-normal continuous | Median (IQR) or Median [range] |
|
|
182
|
+
| Categorical | n (%) |
|
|
183
|
+
|
|
184
|
+
### Inferential Statistics
|
|
185
|
+
Always report: test statistic, degrees of freedom, p-value, effect size
|
|
186
|
+
|
|
187
|
+
```
|
|
188
|
+
t(48) = 2.31, p = .025, d = 0.67
|
|
189
|
+
F(2, 147) = 4.56, p = .012, η² = 0.06
|
|
190
|
+
χ²(2) = 8.92, p = .012, V = 0.21
|
|
191
|
+
r = .45, p < .001
|
|
192
|
+
OR = 2.3, 95% CI [1.4, 3.8]
|
|
193
|
+
```
|
|
194
|
+
|
|
195
|
+
### P-value Conventions
|
|
196
|
+
- Report exact values: p = .034, not p < .05
|
|
197
|
+
- For very small: p < .001
|
|
198
|
+
- Never p = .000
|
|
199
|
+
|
|
200
|
+
### Effect Size Interpretation (Cohen's conventions)
|
|
201
|
+
| Measure | Small | Medium | Large |
|
|
202
|
+
|---------|-------|--------|-------|
|
|
203
|
+
| d | 0.2 | 0.5 | 0.8 |
|
|
204
|
+
| r | 0.1 | 0.3 | 0.5 |
|
|
205
|
+
| η² | 0.01 | 0.06 | 0.14 |
|
|
206
|
+
|
|
207
|
+
---
|
|
208
|
+
|
|
209
|
+
## Quality Checklist
|
|
210
|
+
|
|
211
|
+
### Figures
|
|
212
|
+
- [ ] High resolution (300+ DPI)
|
|
213
|
+
- [ ] Axes labeled with units
|
|
214
|
+
- [ ] Legend included and clear
|
|
215
|
+
- [ ] Error bars defined
|
|
216
|
+
- [ ] Colorblind accessible
|
|
217
|
+
- [ ] Caption complete and standalone
|
|
218
|
+
|
|
219
|
+
### Tables
|
|
220
|
+
- [ ] Title descriptive
|
|
221
|
+
- [ ] Headers clear with units
|
|
222
|
+
- [ ] Decimal places consistent
|
|
223
|
+
- [ ] Abbreviations defined
|
|
224
|
+
- [ ] Sample sizes included
|
|
225
|
+
- [ ] Statistical results complete
|